866-997-4948(US-Canada Toll Free)

Ovarian Cancer Global Clinical Trials Review, H2, 2012

Published By :

GlobalData

Published Date : Nov 2012

Category :

Ovarian Cancer

No. of Pages : 140 Pages

 

Ovarian Cancer Global Clinical Trials Review, H2, 2012

 

Summary

 

GlobalData's clinical trial report, Ovarian Cancer Global Clinical Trials Review, H2, 2012" provides data on the Ovarian Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ovarian Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ovarian Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

 

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

 

Scope

 

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations 
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

 

Reasons to buy

 

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents


Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Ovarian Cancer 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Ovarian Cancer 24
Subjects Recruited Over a Period of Time 38
Prominent Sponsors 39
Top Companies Participating in Ovarian Cancer Therapeutics Clinical Trials 41
Prominent Drug Comparison 43
Clinical Trial Profiles 44
Clinical Trial Overview of Top Companies 44
Eli Lilly and Company 44
Clinical Trial Overview of Eli Lilly and Company 44
AstraZeneca PLC 46
Clinical Trial Overview of AstraZeneca PLC 46
GlaxoSmithKline plc 48
Clinical Trial Overview of GlaxoSmithKline plc 48
Sanofi 49
Clinical Trial Overview of Sanofi 49
Amgen Inc. 50
Clinical Trial Overview of Amgen Inc. 50
Merck & Co., Inc. 51
Clinical Trial Overview of Merck & Co., Inc. 51
Genentech, Inc. 53
Clinical Trial Overview of Genentech, Inc. 53
Bristol-Myers Squibb Company 54
Clinical Trial Overview of Bristol-Myers Squibb Company 54
Morphotek, Inc. 55
Clinical Trial Overview of Morphotek, Inc. 55
Telik, Inc. 56
Clinical Trial Overview of Telik, Inc. 56
Abbott Laboratories 57
Clinical Trial Overview of Abbott Laboratories 57
Johnson & Johnson 58
Clinical Trial Overview of Johnson & Johnson 58
Bayer AG 59
Clinical Trial Overview of Bayer AG 59
Fresenius Biotech GmbH 60
Clinical Trial Overview of Fresenius Biotech GmbH 60
Endocyte, Inc. 61
Clinical Trial Overview of Endocyte, Inc. 61
Hoffmann-La Roche Inc. 62
Clinical Trial Overview of Hoffmann-La Roche Inc. 62
Merck KGaA 63
Clinical Trial Overview of Merck KGaA 63
EntreMed, Inc. 64
Clinical Trial Overview of EntreMed, Inc. 64
MEI Pharma, Inc. 65
Clinical Trial Overview of MEI Pharma, Inc. 65
Unither Pharmaceuticals 66
Clinical Trial Overview of Unither Pharmaceuticals 66
Clinical Trial Overview of Top Universities / Institutes / Hospitals 67
Memorial Sloan Kettering Cancer Center 67
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 67
The University of Texas M. D. Anderson Cancer Center 74
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 74
Fred Hutchinson Cancer Research Center 77
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 77
Dana-Farber Cancer Institute 80
Clinical Trial Overview of Dana-Farber Cancer Institute 80
Masonic Cancer Center 82
Clinical Trial Overview of Masonic Cancer Center 82
Mayo Clinic 84
Clinical Trial Overview of Mayo Clinic 84
New York University School of Medicine 86
Clinical Trial Overview of New York University School of Medicine 86
National Taiwan University Hospital 87
Clinical Trial Overview of National Taiwan University Hospital 87
Case Comprehensive Cancer Center 88
Clinical Trial Overview of Case Comprehensive Cancer Center 88
Wake Forest University 89
Clinical Trial Overview of Wake Forest University 89
City of Hope National Medical Center 90
Clinical Trial Overview of City of Hope National Medical Center 90
Duke University 91
Clinical Trial Overview of Duke University 91
University of Alabama at Birmingham 92
Clinical Trial Overview of University of Alabama at Birmingham 92
Massachusetts General Hospital 93
Clinical Trial Overview of Massachusetts General Hospital 93
H. Lee Moffitt Cancer Center & Research Institute 94
Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute 94
Roswell Park Cancer Institute 95
Clinical Trial Overview of Roswell Park Cancer Institute 95
Barbara Ann Karmanos Cancer Institute 96
Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute 96
Abramson Cancer Center 97
Clinical Trial Overview of Abramson Cancer Center 97
University of Pittsburgh 98
Clinical Trial Overview of University of Pittsburgh 98
Beth Israel Deaconess Medical Center 99
Clinical Trial Overview of Beth Israel Deaconess Medical Center 99
Five Key Clinical Profiles 100


Appendix 137
Abbreviations 137
Definitions 137
Research Methodology 138
Secondary Research 138
About GlobalData 139
Contact Us 139
Disclaimer 139
Source 140

List of Table


Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8
Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Ovarian Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Ovarian Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11
Ovarian Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12
Ovarian Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012* 13
Ovarian Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012* 14
Ovarian Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 15
Ovarian Cancer Therapeutics Clinical Trials, BRIC Countries, 2012* 16
Ovarian Cancer Therapeutics Clinical Trials, G7 Countries, 2012* 17
Ovarian Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Ovarian Cancer Therapeutics Clinical Trials, E7 Countries, 2012* 19
Ovarian Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21
Ovarian Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22
Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Ovarian Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2012* 24
Ovarian Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 26
Ovarian Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012* 28
Ovarian Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 38
Ovarian Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 40
Ovarian Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 42
Ovarian Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 43
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 44
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 46
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 48
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 49
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012* 50
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 51
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Genentech, Inc., 2012* 53
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012* 54
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Morphotek, Inc., 2012* 55
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Telik, Inc., 2012* 56
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012* 57
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012* 58
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012* 59
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fresenius Biotech GmbH, 2012* 60
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Endocyte, Inc., 2012* 61
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Hoffmann-La Roche Inc., 2012* 62
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck KGaA, 2012* 63
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by EntreMed, Inc., 2012* 64
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by MEI Pharma, Inc., 2012* 65
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Unither Pharmaceuticals, 2012* 66
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 67
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 74
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012* 77
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012* 80
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2012* 82
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 84
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2012* 86
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2012* 87
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012* 88
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012* 89
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2012* 90
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012* 91
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2012* 92
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012* 93
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 2012* 94
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012* 95
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2012* 96
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Abramson Cancer Center, 2012* 97
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012* 98
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Beth Israel Deaconess Medical Center, 2012* 99

List of Chart


Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8
Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Ovarian Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Ovarian Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11
Ovarian Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12
Ovarian Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 13
Ovarian Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012* 14
Ovarian Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 15
Ovarian Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16
Ovarian Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012* 17
Ovarian Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Ovarian Cancer Therapeutics Clinical Trials, E7 Countries (%), 2012* 19
Ovarian Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21
Ovarian Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22
Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Ovarian Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 38
Ovarian Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 39
Ovarian Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 41
Ovarian Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 43
GlobalData Methodology 138

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *